Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep200 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Immune checkpoint inhibitor (ICPi)-induced de novo type 1 diabetes mellitus: a case report

Borg Maria , Busuttil Zachary , Mifsud Simon , Gatt Arlene , Mifsud Taliana Kelly , Vella Sandro

Background: Immune checkpoint inhibitors (ICPis) have become a cornerstone of cancer management. Whilst endocrine-related adverse effects are one of the most common immune-related adverse events, ICPi-induced de novo diabetes occurs at low frequencies1. We describe a case of ICPi-induced de novo type 1 diabetes presenting with severe diabetic ketoacidosis (DKA) in a female with metastatic melanoma.Case report: A 50-year-old l...

ea0099ep370 | Reproductive and Developmental Endocrinology | ECE2024

Delayed puberty and ataxia – important clinical manifestations of polr3b-related leukodystrophy

Mifsud Simon , Debono Miguel

Background: POLR3-related leukodystrophy is an autosomal recessive hypo-myelinating leukodystrophy characterized by specific features on MRI and varying combinations of four major clinical findings1. The latter include neurological dysfunction, abnormal dentition, endocrine dysfunction, and myopia1. Endocrine dysfunction in POLR3-related leukodystrophy includes hypogonadotropic-hypogonadism (HH), short stature, growth hormone deficiency, and less commonly...

ea0062wa11 | Workshop A: Disorders of the hypothalamus and pituitary | EU2019

Parasellar meningioma: an insidious impersonator

Mifsud Roberta , Cachia Mario J. , Gruppetta Mark

The patient is a 45 year old gentleman known case of HIV seropositivity (well-controlled, undetectable viral load) and polycystic kidney disease, who was referred to our Endocrine clinic by the Infectious disease specialists in view of a 4 year history of erectile dysfunction (ED – preceded diagnosis of HIV) and a low testosterone level. During the first consultation, the patient reported occasional lethargy and long term nausea which was attributed to his retroviral trea...

ea0062cb14 | Additional Cases | EU2019

A case of amiodarone-induced hypothyroidism

Mifsud Simon , Imbroll Miriam Giordano , Gruppetta Mark

A sixty-four-year old lady with a past medical history of total thyroidectomy for Graves’ disease and atrial fibrillation on amiodarone was referred to the endocrine out-patients in view of hypothyroidism. Since starting amiodarone, the TSH was noted to be elevated at 75 mU/l and the free T4 was 18 pmol/l. The patient complained of non-specific lethargy and was administered levothyroxine 50 mcg daily. Despite this her TSH remained elevated at 147 mU/l with a free T4 of 17...

ea0099p167 | Thyroid | ECE2024

Characterizing TSH-receptor antibody (TRAb) seropositive and TRAb seronegative patients with Graves hyperthyroidism - a cross-sectional study

Mifsud Simon , Gauci Zachary , Vella Sandro

Background: The concept of autoantibody-negative Graves’ disease (GD) is a subject of debate. Studies have revealed that autoantibody-negative GD does exist, albeit rare.1Method: Over a 3-year period, a total of 108 hyperthyroid patients who exhibited diffuse or normal thyroid uptake on thyroid scintigraphy, were assessed in a cross-sectional study. The thyroid function tests, TSH-receptor antibody (TRAb) levels, anti-thyroid peroxidase (anti-TPO) a...

ea0099oc3.6 | Oral Communications 3: Adrenal and Cardiovascular Endocrinology | Part I | ECE2024

Multiple dosing of immediate-release hydrocortisone is associated with a greater risk of hypothalamic-pituitary-adrenal axis suppression when compared to low-dose prednisolone when weaning in steroid-induced adrenal insufficiency

Mifsud Simon , Mifsud Emma Louise , Newell-Price John , Ross Richard , Debono Miguel

Background: Long-term glucocorticoids can result in iatrogenic Cushing’s syndrome with adrenal suppression. Most patients reactivate their hypothalamic-pituitary-adrenal axis once they’re weaned off glucocorticoids. During glucocorticoid withdrawal, many clinicians switch patients to hydrocortisone to benefit from its short half-life1. However, in some patients, hypothalamic-pituitary-adrenal axis recovery is delayed despite the above. It is unclear whethe...

ea0065p406 | Thyroid | SFEBES2019

Radioiodine therapy for Grave’s disease: does post treatment block and replace therapy reduce the incidence of biochemical hypothyroidism?

Mckirdy Fiona , Kelly Chris

Prior to therapy, patients choosing I131 therapy for the treatment of Grave’s disease were pre treated with carbimazole. Post I131 they have their thyroid function checked monthly in primary care prior to clinic review at 3 months. Carbimazole can be restarted if clinically indicated and treatment with thyroxine was recommended if their TSH was greater than 3.5 mU/l (ref range 0.35–5.5). A previous audit had demonstrated that 24% of patients had an elevated TSH great...

ea0044ep114 | (1) | SFEBES2016

Thymic hyperplasia in Graves’ disease: case presentation and review of current literature

Lewis Alex , Cheer Kelly

A 37-year-old Nigerian lady was referred to the endocrinology clinic with worsening dyspnoea, weight loss, poor sleep and palpitations over the preceding few months. She had a past history of depression treated with citalopram. She was clinically and biochemically thyrotoxic with a TSH <0.01 μ/l [0.4–5] and free T4 49.3 pmol/l [9–19]. TSH receptor antibodies were positive. She was commenced on carbimazole 40 mg once daily and propranolol 40 mg twi...

ea0029n18 | (1) | ICEECE2012

Molecular genetics in turner syndrome

Behm Kelly Mullholand

The basics of molecular genetics are reviewed with emphasis on introducing terminology frequently encountered in genetic lab results and in lectures focusing on the genetic origins of disease. Mutations thought to be associated with various phenotypical features of Turner syndrome are identified. Specific examples of genetic test results revealing Turner syndrome are reviewed. The new molecular testing available for diagnosing Turner syndrome is presented. Applications to the ...

ea0029n19 | (1) | ICEECE2012

An Internet based protocol for examining transitional experiences of 16–26 year olds with Turner syndrome (TS)

Behm Kelly Mullholand

Problem: Programs for adolescents with Turner syndrome (TS) are currently based on evidence derived from medical surveillance or parental and teacher perceptions. Little is known about how personal perceptions in this population influence behavior and psychosocial outcomes. Facing issues associated with puberty and young adulthood, such as body image, relationships, and careers, can be more challenging when living with TS.Framework: Unlike frameworks for...